Issued Patents All Time
Showing 1–8 of 8 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12077526 | Isoindolinone inhibitors of the MDM2-P53 interaction and process for making them | Steven Howard, Benjamin David CONS, Rhian Sara HOLVEY, Guillaume François PARRA, Kim Louise Hirst +11 more | 2024-09-03 |
| 12071429 | Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity | Gianni Chessari, Steven Howard, Ildiko Maria Buck, Benjamin David CONS, Christopher Norbert Johnson +16 more | 2024-08-27 |
| 12037345 | Heterobicyclic compounds for inhibiting the activity of SHP2 | Tadashi Shimamura, Ryo KATO, Risako MIURA, Takashi Mita, Takahiro Ogawa +5 more | 2024-07-16 |
| 11603367 | Isoindolinone inhibitors of the MDM2-P53 interaction and process for making them | Steven Howard, Charlotte Mary Griffiths-Jones, Steven Douglas Hiscock, Alan Richard BURNS, David Cousin +11 more | 2023-03-14 |
| 11261171 | Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity | Gianni Chessari, Steven Howard, Ildiko Maria Buck, Benjamin David CONS, Christopher Norbert Johnson +16 more | 2022-03-01 |
| 10981898 | Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity | Gianni Chessari, Steven Howard, Ildiko Maria Buck, Benjamin David CONS, Christopher Norbert Johnson +16 more | 2021-04-20 |
| 10544132 | Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity | Gianni Chessari, Steven Howard, Ildiko Maria Buck, Benjamin David CONS, Christopher Norbert Johnson +16 more | 2020-01-28 |
| 10526311 | Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity | Gianni Chessari, Steven Howard, Ildiko Maria Buck, Benjamin David CONS, Christopher Norbert Johnson +16 more | 2020-01-07 |